During the COVID-19 crisis, a number of the ongoing worldwide HIV vaccine and immunotherapy efficacy trials are being paused or curtailed, reports Aidsmap.
The HIV Vaccines Trial Network (HVTN) originally announced on Monday 24 March that several of the large prevention efficacy trials it oversees would be curtailed or paused. Since then, a number of other study investigators have announced that their studies will be shortened, paused or postponed.
[link url="https://www.avac.org/covid-19-implications-hiv-prevention-trials"]COVID-19 implications of HIV Prevention Trials[/link]